Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Azurity – Recall of Zenzedi® (dextroamphetamine)

January 24, 2024 - Azurity announced a consumer level recall of one lot of Zenzedi (dextroamphetamine) 30 mg tablets because a bottle labeled as Zenzedi contained carbinoxamine tablets.

Download PDF

Rx navigation